AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.

We know that our future depends on taking bold action for the health of people, society, and the planet. At AstraZeneca, sustainability is part of our DNA, embedded in everything we do, from the lab to the patient.

2025年1月23日 · 700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies . AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled ...

5 天之前 · AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision ...

2025年1月26日 · AstraZeneca, a British-Swedish biopharmaceutical company, is one of the largest drug companies in the world. Top research and development areas include oncology, rare diseases, and biopharmaceutical intervention.

AstraZeneca is a key partner in the current process of transformation of health systems by providing innovative solutions that allow us to face the new care, economic, social and technological paradigms. Ensuring access to healthcare for thousands of people worldwide with innovative therapies.

AstraZeneca aims to transform the treatment of asthma and chronic obstructive pulmonary disease (COPD) by eliminating preventable asthma attacks across all severities and removing COPD as a leading cause of death through earlier, biology-led treatment.

2025年1月2日 · AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); and Rare Disease.

By signing up, I acknowledge I have read the AstraZeneca privacy policy, and I wish to receive email communications and SMS communications. I understand I can opt-out from receiving email and SMS communications at any time. Sign up. Created with Sketch. Please be aware of any suspicious email activity from people who could be pretending to be ...